The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is accepting applications for up to two community representatives to serve a four-year term beginning April 2027, with potential for reappointment for one additional term. The Panel welcomes candidates who are able to represent communities affected by HIV. Community members may assist the Panel in identifying and addressing unique aspects of treatment that relate to the communities they represent. The candidate shall have knowledge and involvement in issues related to antiretroviral therapy (ART) among adults and adolescents with HIV in the United States, as evidenced by experience in education and/or advocacy or clinical and/or public policy initiatives related to HIV treatment.  

The Panel is a working group of the Office of AIDS Research Advisory Council of the National Institutes of Health, comprised of over 40 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV treatment in the United States. The Panel meets monthly (with subgroups meeting more frequently as needed) via videoconferencing to review and critically evaluate emerging scientific data relating to ART and to revise the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV.  

Panel members are not financially compensated for their time commitment. Panel members are required to report any relationships with companies involved with antiretroviral agents or diagnostic tests relevant to ART and may not take part in pharmaceutical companies’ speakers bureaus while on the Panel. 

Self-nominations are welcome. Applicants should include a resume (or bio) and a brief letter of interest describing how they would contribute to the work of the Panel.  

All supporting documents must be submitted to the Executive Secretary, Safia Kuriakose, Pharm.D. ([email protected]), and the Program Manager, Marylu Schaffhauser ([email protected]), electronically by January 11, 2027 (firm).